Novo Nordisk invests €2.1B in Chartres production site expansion

Novo Nordisk announced an investment of more than 16 billion Danish kroner (€2.1 billion) to expand its production site in Chartres, France, adding aseptic and finished production processes and a quality control lab, creating over 500 jobs.

“This significant investment announced today confirms the importance of our French manufacturing site, one of our strategic production sites, as a cornerstone of the growth we are experiencing as a company.”globenewswire.com

• 1 source
• globenewswire.comNovo Nordisk invests more than 16 billion Danish kroner inNovo Nordisk A/SNov 23, 2023

Summarized from public sources; check the original articles before acting on it.